Research
WU Jianrong
-
Graduate Supervisor,
Associate Researcher
- Department: Ultrasound in Medicine
- Research Area:
Imaging and Nuclear Medicine (Ultrasound)
- Research Interests:
Imaging guided drug delivery and drug detection
- Contact: wujianrong028@shsmu.edu.cn
- Fellowship, Department of Ultrasound Medicine, Shanghai Sixth People’s Hospital, 2022
- Postdoc at Shanghai Jiao Tong University School of Medicine, 2022
- PhD from Donghua University, 2019
- MSC from China Pharmaceutical University, 2016
- Council member, Shanghai Acoustical Society
- Editorial Board, Journal Of Cluster Science
- Geyong Guo#, Zihao Liu#, Jinlong Yu#, Yanan You, Mingzhang Li, Boyong Wang, Jin Tang, Pei Han, Jianrong Wu*, Hao Shen*, Neutrophil Function Conversion Driven by Immune Switchpoint Regulator Against Diabetes-Related Biofilm Infections. Advanced Materials, 2024, DOI: 10.1002/adma.202310320.
- Jianing Ding, Xin Wang, Wei Liu, Cheng Ding, Jianrong Wu,* Renke He,* Xianlong Zhang*. Biofilm Microenvironment Activated Antibiotic Adjuvant for Implant-Associated Infections by Systematic Iron Metabolism Interference, Advanced Science, 2024, DOI: 10.1002/advs.202400862.
- Longchen Wang#, Weijuan Zou#, Jian Shen, Shihao Yang, Jingjing Wu, Tao Ying*, Xiaojun Cai, Li Zhang*, Jianrong Wu*, Yuanyi Zheng*. Dual-functional Laser Guided Locomotion of Magnetic Nanorobot Collectives Against Gravity for On-demand Thermo-chemotherapy of Peritoneal Metastasis, Advanced Healthcare Materials, 2023, DOI: 10.1002/adhm.202303361.
- Weijuan Zou#, Feng Gao#, Zheying Meng, Xiaojun Cai, Wu Chen, Yuanyi Zheng, Tao Ying*, Longchen Wang*, Jianrong Wu*. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy, Journal of Colloid and Interface Science, 2024, doi: 10.1016/j.jcis.2024.03.001.
- Tongtong Nie#, Weijuan Zou#, Zheying Meng, Longchen Wang, Tao Ying, Xiaojun Cai, Jianrong Wu*, Yuanyi Zheng*, and Bing Hu*. Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-like Cancer Cell Death. Advanced Materials, 2022, DOI: 10.1002/adma.202206286.
- Weijuan Zou#, Longchen Wang#, Junnian Hao, Lixian Jiang, Wenxian Du*, Tao Ying, Xiaojun Cai, Haitao Ran, Jianrong Wu*, Yuanyi Zheng*. Phase-change cascaded nanomedicine for intensive photothermal-enhanced nanocatalytic therapy via tumor oxidative stress amplification. Composites Part B-Engineering, 2022, doi: 10.1016/j.compositesb.2022.109707.
- Longchen Wang#, Jienan Wang#, Junnian Hao#, Ziliang Dong, Jianrong Wu*, Guofeng Shen, Tao Ying, Liangzhu Feng, Xiaojun Cai, Zhuang Liu, Yuanyi Zheng*. Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C-Shaped Magnetic Actuation System In Vivo. Advanced Materials, 2021, DOI: 10.1002/adma.202105351.
- Jianrong Wu#, Xiaojun Cai#, Gareth R. Williams, Zheying Meng, Weijuan Zou, Li Yao, Bing Hu, Yu Chen*, and Yuanyi Zheng*. 2D antimonene-integrated composite nanomedicine for augmented low-temperature photonic tumor hyperthermia by reversing cell thermoresistance. Bioactive Materials, 2022, doi: j.bioactmat.2021.08.018.
- Jianrong Wu, Zheying Meng, Agata A. Exner, Xiaojun Cai*, Xue Xie, Bing Hu, Yu Chen*, and Yuanyi Zheng*. Biodegradable cascade nanocatalysts enable tumor-microenvironment remodeling for controllable CO release and targeted/synergistic cancer nanotherapy. Biomaterials, 2021, doi: 10.1016/j.biomaterials.2021.121001.
- Jianrong Wu, Gareth R. Williams, Shiwei Niu, Feng Gao, Ranran Tang*, and Li-Min Zhu*. A Multifunctional Biodegradable Nanocomposite for Cancer Theranostics. Advanced Science, 2019, DOI: 10.1002/advs.201802001.
- [Jianrong Wu, Yuanyi Zheng, Weijuan Zou, Xiaojun Cai, Bing Hu] (2023), “The preparation method and biomedical application of a transfection reagent”, CN202311312834.1
- [Yuanyi Zheng, Jianrong Wu, Weijuan Zou, Junnian Hao, Xiaojun Cai, Bing Hu] (2023), “The preparation method of a cationic ultrasound microbubble contrast agent”, CN202311653857.9
- Technological translation achievements (received amount: RMB 1750,000)